08 March 2022: Original Paper
The Role of Cavoportal and Renoportal Hemitransposition in Liver Transplantation
Betty Maillot 1ABCDEF , Guillaume Bouzille 2C , Jean-Yves Mabrut 3B , Edouard Girard 4B , Alexis Laurent 5B , Francis Navarro 6B , Alexandre Chebaro 7B , Laurence Chiche 8B , François Faitot 9B , Laurent Sulpice 1AB , Eric Vibert 10B , Karim Boudjema 1ACDEF*DOI: 10.12659/AOT.935892
Ann Transplant 2022; 27:e935892
Table 6 Comparison of perioperative complications between the HT and OLT groups.
| HTn=64n (%) or median [IQR] | OLT*n=64n (%) or median [IQR] | P-value | |
|---|---|---|---|
| Complications (Clavien-Dindo) | 0.620 | ||
| 27 (48) | 28 (55) | ||
| ≥IIIb | 29 (52) | 23 (45) | |
| Vascular complications | |||
| Thrombosis of the hepatic artery | 9 (14.1) | 4 (6.2) | 0.357 |
| Thrombosis of the portal vein | 10 (15.6) | 0 (0) | |
| Stenosis of the CP or RP anastomosis | 3 (4.7) | 0 (0) | |
| Thrombosis of the vena cava | 2 (3.1) | 1 (1.6) | 1.000 |
| Biliary fistula | 2 (3.1) | 2 (3.1) | 1.000 |
| Graft dysfunction | |||
| PNF | 7 (10.9) | 3 (4.7) | 0.323 |
| Delayed function | 1 (1.6) | 1 (1.6) | 1.000 |
| PHT related complications | |||
| Ascites | 18 (28.1) | 5 (7.8) | 0.006 |
| Hemorrhage | 11 (17.2) | 3 (4.7) | 0.047 |
| Hepatic encephalopathy | 1 (1.6) | 4 (6.2) | 0.365 |
| Renal complications | |||
| Functional ARF | 22 (34.9) | 18 (28.1) | 0.527 |
| Organic ARF | 10 (15.6) | 3 (4.7) | 0.079 |
| Postoperative dialysis | 6 (9.4) | 3 (4.7) | 0.492 |
| Reoperation | 26 (40.6) | 25 (39.1) | 1.000 |
| Retransplantation | 3 (4.8) | 8 (12.5) | 0.217 |
| Hospital length of stay (days) | 29 [19–43] | 19 [15–28] | 0.006 |
| Rehospitalization | 17 (28.8) | 15 (23.8) | 0.673 |
| * Patients were paired to HT group on sex, age, recipient BMI, indication of transplantation, MELD score and cold ischemia time. HT – hemitranspositions; OLT – orthotopic liver transplantation; IQR – interquartile range; PNF – primary nonfunction; PHT – portal hypertension; ARF – acute renal failure. | |||